NAS:CNCR

Range Cancer Therapeutics ETF

$ 14.28 -0.2 ( -1.38%) 02:28 PM EST
PE Ratio:
20.85
PB Ratio:
2.06
Volume:
2.21K
Dividend Yield %:
0
Last Holding update 2024-02-01 86 Stocks (0 new)
Value $11.00 Mil Turnover 28 %
Portfolio Report
Registrant: Range Cancer Therapeutics ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
This section is for PremiumPlus P  Membership subscribers only.
GuruFocus PremiumPlus P  Membership
  Backtesting
  13F, 13D/G of all institutional investors
  Aggregated portfolio of any combinations among them
  FilingWiz
  Manual of Stocks
  Excel Add-In unlimited queries
  API (20,000 queries/month)

Discussions on Range Cancer Therapeutics ETF

How would you rate this stock? CNCR
No discussions yet.